October 30 2021 – Delray Medical Center recently published a breakthrough study focusing on 5ALA (fluorescent guided surgery) for glioblastomas, with the team at the Mount Sinai Hospital. The clinical trial took place at Delray Medical Center, and led by Dr. Lloyd Zucker, Chief of Neurosurgery at Delray Medical Center.  The study, taking place over a five-year period, is now published in the Journal of Neurosurgery, one of the largest peer reviewed neurosurgical journals in the world.

“I am honored to have participated in this incredible and innovative study with Mount Sinai. The medical community now has a better way to treat patients who have been diagnosed with glioblastoma brain tumors,” said Dr. Zucker. “Having Delray Medical Center be the site for published studies such as this one for fluorescent guided brain tumor surgery, shows how we are providing state of the art care right here in our community.”     

Fluorescent guided surgery is used to give surgeons the ability to ‘see’ in a different wavelength of light that would otherwise be invisible to them. By combining this visual ability with the special dyes that glow in those wavelengths, surgeons can much more precisely target cancerous tumors and avoid injury to normal tissues.

“We want to congratulate our medical director Dr. Zucker, and the neurosurgery team at Delray Medical Center for their hard work and dedication to getting this study published, and continuing their research when it comes to brain tumors and cancers,” said Maggie Gill, Chief Executive Officer of the Palm Beach Health Network and Delray Medical Center.  “Studies such as this one continue to show why Delray Medical Center is at the forefront when it comes to medical advances for neurological care.”

About Delray Medical Center

For nearly 40 years, Delray Medical Center, part of the Palm Beach Health Network, is a 523-bed acute care hospital, has served the communities of South Palm Beach County. As both a community hospital and state-designated Level I Trauma Center located on a 42-acre medical plaza, Delray Medical Center has the ability to offer several specialized services including cardiac care, orthopedics, rehabilitation, neurosciences, emergency care and more.

For the past 14 years, Delray Medical Center has been named one of America’s 50 Best Hospitals by Healthgrades®, a leading independent healthcare ratings organization. Delray Medical Center is a recipient of the Healthgrades 2020 Patient Safety Excellence Award, a designation recognizing superior performance of hospitals preventing the occurrence of serious, potentially avoidable complications for patients during hospital stays.  The hospital is also a Five-Star Recipient for Treatment of Heart Failure for 17 years in a row (2003-2019).

Delray Medical Center is a state-designated Comprehensive Stroke Center by the DNV-GL and received Get With The Guidelines award for advanced therapy for Thrombectomy. In addition, the hospital earned the Get With the Guidelines – Heart Failure and Stroke Gold Plus Quality Achievement Awards from the American Heart Association/American Stroke Association in 2020. Delray Medical Center was also named by Healthgrades as a Five-Star Recipient for Treatment of Stroke for 12 years in a row (2008-2020).  Pinecrest Rehabilitation and Outpatient Hospital at Delray Medical Center is a CARF accredited rehabilitation unit, and the only state designated brain and spinal cord injury rehabilitation program in Palm Beach County by the state of Florida, Department of Health.